{"disease":{"id":"left-ventricular-function","name":"left ventricular function"},"drugs":{"marketed":[{"drug_id":"valsartan","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diovan","generic_name":"VALSARTAN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":"447","mechanism":"Diovan works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"diovan","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diovan","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Platelet glycoprotein VI, Type-1 angiotensin II receptor, Angiotensin II receptor (AT-1) type-1","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"fludeoxyglucose","indication_name":"left ventricular dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"FLUDEOXYGLUCOSE","company_name":"Downstate Clincl","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions."},{"drug_id":"fludeoxyglucose","indication_name":"coronary artery disease and left ventricular dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"FLUDEOXYGLUCOSE","company_name":"Downstate Clincl","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions."},{"drug_id":"f-18","indication_name":"left ventricular dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"F-18","company_name":"3D Imaging Drug","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions."},{"drug_id":"f-18","indication_name":"coronary artery disease and left ventricular dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"F-18","company_name":"3D Imaging Drug","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions."},{"drug_id":"enalapril-maleate","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"glyceryl-trinitrate","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nitroglycerin","generic_name":"glyceryl trinitrate","company_name":"Fougera","drug_phase":"marketed","molecular_target":"guanylate cyclase","drug_class":"Nitrate Vasodilator [EPC]","quality_score":65,"revenue":null,"mechanism":"Nitroglycerin forms nitric oxide, activating guanylate cyclase and increasing cyclic GMP, leading to smooth muscle relaxation and vasodilation."},{"drug_id":"captopril","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Capozide 25/15","generic_name":"CAPTOPRIL","company_name":"Aarxion Anda Hlding","drug_phase":"marketed","molecular_target":"Renin","drug_class":"Thiazide Diuretic [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"enalapril","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"enalapril","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme, Angiotensin-converting enzyme","drug_class":"ACE inhibitor","quality_score":60,"revenue":null,"mechanism":"ACE inhibitor prodrug that is converted to enalaprilat, blocking angiotensin-converting enzyme to lower blood pressure."},{"drug_id":"carvedilol","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coreg","generic_name":"CARVEDILOL","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"alpha-Adrenergic Blocker [EPC]","quality_score":70,"revenue":null,"mechanism":"Coreg works by blocking the effects of the hormone epinephrine on the heart, reducing its workload and improving its function."},{"drug_id":"enalaprilat","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRILAT","company_name":"Biovail Labs Intl","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"enalaprilat","quality_score":75,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"ramipril","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Altace","generic_name":"RAMIPRIL","company_name":"King Pfizer","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor [EPC]","quality_score":80,"revenue":null,"mechanism":"Altace works by blocking the action of angiotensin-converting enzyme, a key player in the renin-angiotensin-aldosterone system that regulates blood pressure."},{"drug_id":"nitroglycerine","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"nitroglycerine","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"enalapril-maleate","indication_name":"Asymptomatic Left Ventricular Dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"mavik","indication_name":"Left ventricular cardiac dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mavik","company_name":"Dr. Reddy's Laboratories Limited","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07515859","title":"Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography","phase":"","overall_status":"COMPLETED","enrollment_count":31486,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05117970","title":"Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms","phase":"NA","overall_status":"COMPLETED","enrollment_count":13631,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT07355023","title":"AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Tri-Service General Hospital","has_results":false},{"nct_id":"NCT06811519","title":"AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05010655","title":"Low Ejection Fraction in Single Lead ECG","phase":"","overall_status":"COMPLETED","enrollment_count":1935,"lead_sponsor_name":"Eko Devices, Inc.","has_results":false},{"nct_id":"NCT03735251","title":"Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study","phase":"","overall_status":"COMPLETED","enrollment_count":1920,"lead_sponsor_name":"Ya-Wei Xu","has_results":false},{"nct_id":"NCT06231797","title":"AI-ECG Screening for Left Ventricular Systolic Dysfunction","phase":"","overall_status":"UNKNOWN","enrollment_count":1530,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05647577","title":"The Relationship Between Inflammatory ARTritis and CArdiac DIseAse","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1285,"lead_sponsor_name":"University Hospital, Gentofte, Copenhagen","has_results":false},{"nct_id":"NCT04400435","title":"Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence","phase":"","overall_status":"COMPLETED","enrollment_count":1258,"lead_sponsor_name":"Eko Devices, Inc.","has_results":false},{"nct_id":"NCT05861115","title":"A Study to Evaluate Accuracy and Validity of the \"Chang Gung\" Ventricular Systolic Dysfunction Screening Software","phase":"NA","overall_status":"COMPLETED","enrollment_count":1172,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03319160","title":"LifeVest Safety and Efficacy in Real Life Settings in France","phase":"","overall_status":"COMPLETED","enrollment_count":1164,"lead_sponsor_name":"Zoll Medical Corporation","has_results":true},{"nct_id":"NCT04950218","title":"Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT04405856","title":"Outcome of Patients Treated With IABP","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT04397302","title":"Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction","phase":"","overall_status":"COMPLETED","enrollment_count":652,"lead_sponsor_name":"Italian Society of Cardiology","has_results":false},{"nct_id":"NCT04249648","title":"Hyperkalaemia and Its Impact on Therapy with RAASi","phase":"","overall_status":"COMPLETED","enrollment_count":651,"lead_sponsor_name":"Portsmouth Hospitals NHS Trust","has_results":false},{"nct_id":"NCT07512310","title":"Non-Invasive and Invasive Assessment of Heart Filling Pressure","phase":"","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT05860504","title":"Acute Cardiac Dysfunction in Critical Illnes","phase":"","overall_status":"UNKNOWN","enrollment_count":592,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT03257436","title":"Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)","phase":"NA","overall_status":"COMPLETED","enrollment_count":586,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT01786512","title":"COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":544,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT06221891","title":"Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05208567","title":"London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT05764109","title":"Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation","phase":"","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"Istituti Clinici Scientifici Maugeri SpA","has_results":false},{"nct_id":"NCT05764057","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03787810","title":"Left Ventricular Dysfunction in Critically Ill Patients","phase":"","overall_status":"COMPLETED","enrollment_count":428,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT04505449","title":"Invasive Left Heart Catheterization Registry","phase":"","overall_status":"COMPLETED","enrollment_count":404,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT04871126","title":"Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction","phase":"","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"Henan Provincial People's Hospital","has_results":false},{"nct_id":"NCT04000087","title":"ECG AI-Guided Screening for Low Ejection Fraction","phase":"NA","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03962166","title":"Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":353,"lead_sponsor_name":"Helena DOMINGUEZ","has_results":false},{"nct_id":"NCT05714085","title":"Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05010642","title":"Low Ejection Fraction in Single Lead ECG- Ochsner","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Eko Devices, Inc.","has_results":false},{"nct_id":"NCT04699565","title":"Characterization of Patients With Post-ischemic Left Ventricular Dysfunction","phase":"","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT02956577","title":"Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Svendborg Hospital","has_results":false},{"nct_id":"NCT06949748","title":"Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Athens","has_results":false},{"nct_id":"NCT05619653","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":279,"lead_sponsor_name":"Valentina Puentmann","has_results":false},{"nct_id":"NCT04228874","title":"Effect of Stent Size on Dyssynchrony","phase":"","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT05388032","title":"Sodium Lowering Vascular Effects Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"Tulane University","has_results":false},{"nct_id":"NCT04687111","title":"Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Mark Ledwidge","has_results":false},{"nct_id":"NCT05989945","title":"HIDRAdenitis Suppurativa and HEART Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT05317286","title":"LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Montreal Heart Institute","has_results":false},{"nct_id":"NCT03522194","title":"Left Ventricular Diastolic Function During Anesthesia Induction","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT05161104","title":"A Multicenter Cross-sectional Study of Cardiac Ultrasound Phenotypes in Patients With Sepsis","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Fujian Provincial Hospital","has_results":false},{"nct_id":"NCT04774523","title":"Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization","phase":"NA","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Biotronik SE & Co. KG","has_results":false},{"nct_id":"NCT03755570","title":"How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?","phase":"","overall_status":"SUSPENDED","enrollment_count":198,"lead_sponsor_name":"Royal Cornwall Hospitals Trust","has_results":false},{"nct_id":"NCT06356727","title":"Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT00359372","title":"Predicting Response to Cardiac Resynchronization Therapy in Heart Failure","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05434962","title":"The Left Bundle Cardiac Resynchronization Therapy Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Óscar Cano Pérez","has_results":false},{"nct_id":"NCT04166331","title":"Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT04524234","title":"Cardiac Dysfunction in Critically Ill Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT04231331","title":"Ertugliflozin for Functional Mitral Regurgitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Asan Medical Center","has_results":true},{"nct_id":"NCT05756751","title":"IMPACT EU Post-Market Clinical Follow-Up Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":123,"lead_sponsor_name":"Abiomed Inc.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}